|
MYH9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.478200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.926000E-01 |
| Normal-vs-Stage2 |
6.812800E-01 |
| Normal-vs-Stage3 |
6.304400E-01 |
| Normal-vs-Stage4 |
6.036600E-01 |
| Stage1-vs-Stage2 |
7.502600E-01 |
| Stage1-vs-Stage3 |
6.200800E-01 |
| Stage1-vs-Stage4 |
7.788200E-01 |
| Stage2-vs-Stage3 |
9.676800E-01 |
| Stage2-vs-Stage4 |
9.676800E-01 |
| Stage3-vs-Stage4 |
9.271000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.861640E-01 |
| Normal-vs-AfricanAmerican |
2.603200E-01 |
| Normal-vs-Asian |
4.071400E-01 |
| Caucasian-vs-AfricanAmerican |
7.534400E-01 |
| Caucasian-vs-Asian |
9.541200E-01 |
| AfricanAmerican-vs-Asian |
7.551000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.257800E-01 |
| Normal-vs-Female |
4.139600E-01 |
| Male-vs-Female |
6.763600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.354410E-01 |
| Normal-vs-Age(41-60Yrs) |
8.372000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.296800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.990210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.121180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.177600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.670400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.795000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.982000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.553200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.832000E-01 |
| Classical-VS-Follicular |
4.37849978496274E-10 |
| Classical-VS-Other |
2.593400E-01 |
| Classical-VS-Normal |
1.939970E-02 |
| Tall-VS-Follicular |
1.365220E-04 |
| Tall-VS-Other |
2.996200E-01 |
| Tall-VS-Normal |
1.295020E-01 |
| Follicular-VS-Other |
3.327600E-01 |
| Follicular-VS-Normal |
3.375100E-03 |
| Other-VS-Normal |
7.129600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.469600E-01 |
| Normal-vs-N1 |
7.779800E-01 |
| N0-vs-N1 |
6.348600E-01 |
|
|
